With regard to HRS–Acute kidney injury (AKI), a multicenter prospective RCT is currently ongoing to evaluate the efficacy of TIPS within 72 h from HRS-AKI diagnosis, compared to the standard of care with terlipressin and albumin (NCT05346393). Here, ALB is linked to acute kidney injury.